Regnum Corp. (RGMP)

[GemBerri]

"For Mr. Shkreli, 35 years old, the risk is worth it. He plans to emerge from jail richer than he entered.

His back-of-the-commissary-envelope calculation indicates that Phoenixus could be worth $3.7 billion by the time he is due to be freed in 2023, according to a person familiar with his thinking. His plan involves acquiring more rare drugs in various stages of development and plowing money into an ambitious research-and-development agenda. Both are guided by his long days reading pharmaceutical research."

https://www.wsj.com/articles/martin-shkreli-steers-his-company-from-prisonwith-contraband-cellphone-11551973574

Although Marty is banned from pharma for life, I don't think this will stop him from using subsidiaries to run pharma companies.

[SmittyInvestor]

Ha, maybe this will help to accelerate their fund raising plans because they need cash.
When they have cash expect them to hire all of their minions over to regnum where the money is. This would help to create all kinds of hype for selling HIV drugs. They may do it again however I am sure they have learned some lessons on how not to get caught the next time.
I am still betting this will get driven up higher for a capital raise before they run into any trouble internally or externally.

thanks for the info, keep posting

[Chuckles759]

Hopefully the corporate "shell game" has enough financial firewall isolation to keep Regnum from feeling this pain.

https://www.cnbc.com/2022/01/31/companies-founded-by-martin-shkreli-will-pay-in-daraprim-case.html

The settlement deal between Vyera Pharmaceutics, its parent firm Phoenixus AG, Shkreli, another former company executive Kevin Mulleady, and Blue Cross has to be approved by a federal judge in Manhattan. Under terms of the proposed settlement, the defendants did not admit wrongdoing.

The up-to-$28 million payout from Vyera and Phoenixus will come from the $40 million that the company earlier agreed to pay to end a lawsuit filed by the Federal Trade Commission, which alleged illegal monopolistic activity.

[Big Brother]

Excellent post agree 100%.

Is it high risk...absolutely...if the regulators even get a whiff of Martin being involved in this in any way, it could be a disaster....but...with high risk comes the potential for high reward.

Leronlimab seems to draw a LOT of investor interest, take that interest and combine it with the microscopic float of RGMP.... and just simply due to the law of supply and demand.... the pps could fly.

I don't know what's going on with Martins stake in Phoenixus, sooner he's bought out the better as far as I'm concerned....but as long as he stays out of RGMP business, I like the odds.

[SmittyInvestor]

I think the reason why they put the selling rights in regnum is so they could raise money in the public market to fund this project. You are correct, lots of things they need to do and they do not have enough people. In a private company, SevenScore, they could have gone to their parent company, bank or another investor for money to fund the project. My opinion is they will use regnum and the public markets to raise money.

I personally dont care if they are successful building a company to sell the drug, dont care if the drug is approved, dont care if owner is banned from US. I am placing my bet on they will pump this stock price up to do a fund raise in the public market. Parent company wont care if they sell 5mil shares for $5 and dilute their ownership because they will then have $25mil to spend where today they dont have any cash value in this shell company.
The drug selling rights to a good HIV drug is the reason to raise money. Regnum didnt have anything to raise money on before, now they do.

maybe cydy will get approved and regnum will hire people and sell this all over and people will make money and the price will go to a $200mil market cap, maybe, I do know, I wont own the stock then as I am just here for the bet that they drive the price up to raise cash so this is a quick turn around for me.

I am Investing/gambling on the situation I see, not really the company

[DreyDreyDrey]

The more I am Google Fu’ing this. All from publicly available info, message boards, conspiracy theorist sites, and some guessing. I think Phoenixus has hidden offshore funds from Martin Shkreli that will be available to Regnum. I would also hypothesize that he will fund it, and then bleed it dry in some complex, sadly legal way.

[DreyDreyDrey]

Can someone smarter than me tell me if this is relevant?

"Phoenixus AG, a corporation organized under the laws of Switzerland and holder of (a) 99% of the issued and outstanding
shares of Regnum, and (b) 100% of the issued and outstanding membership interest units of SevenScore (“Phoenixus”)."

So Phoenixus is a Swiss Company. That owns a US drug company Regnum (when I say drug company I mean it as a complete joke").

"'Pharma Bro' Martin Shkreli ordered to repay $64 million and banned for life from drug industry. A federal judge on Friday banned the controversial former pharmaceutical executive Martin Shkreli from ever working in that industry again..."

Maybe he can't be stopped from running a Swiss company, that controls a US drug company? Is this a legal shell game?

[DreyDreyDrey]

Thanks for your post. I strolled over to this ticker to see exactly what the scam is. I don't know what the details of the scam are, and I read your post and I still don't understand. I know it is so shady the sun can't penetrate the canopy over this rip off. Do you have a few minutes to explain it more? I think I understand that they probably have to file these to keep their seedy actions legal. But what is the risk/strategy in the fact that Phoenixus owns Regnum? It sounds like Vyera acquired the rights from Cytodyn, then SevenScore acquired the rights from Vyera, and then SevenScore sold the rights to Regnum while becoming acquired by Phoenixus, which owns Regnum. My gut tells me this all to confuse people, provide protection, and create channels to funnel off money/assets. But how is it actually done?

You wrote:

"Front loaded sell off scam!

Quote:
THIS CONTRIBUTION AGREEMENT (this “Contribution Agreement”) is made effective as of January 3, 2022 (the “Effective Date”), notwithstanding
the actual date of execution hereof, by and among SevenScore Pharmaceuticals, LLC, a Delaware limited liability company (“SevenScore”), Regnum Corp., a
Nevada corporation (“Regnum”) and Phoenixus AG, a corporation organized under the laws of Switzerland and holder of (a) 99% of the issued and outstanding
shares of Regnum, and (b) 100% of the issued and outstanding membership interest units of SevenScore (“Phoenixus”)."

I found this:

"SevenScore Pharmaceuticals LLC entered into an agreement to acquire Regnum Corp. in a reverse merger transaction for $9.8 million.

SevenScore Pharmaceuticals LLC made a proposal to acquire Regnum Corp. (OTCPK:RGMP) from Phoenixus AG and others in a reverse merger transaction for $9.8 million on April 7, 2021. SevenScore Pharmaceuticals LLC entered into an agreement to acquire Regnum Corp. from Phoenixus AG and others in a reverse merger transaction on May 13, 2021. Phoenixus AG (“PAG”) owns approximately 98.9% stake in Regnum. Upon closing, membership interests in SevenScore will be converted into the right to receive an aggregate of 25.9 million shares of common stock of Regnum. Upon effectiveness of the Merger, (i) each share of Regnum Common Stock issued and outstanding and owned by PAG as of immediately prior thereto shall be cancelled and extinguished without any conversion thereof, and (ii) 22,730,409 shares of Regnum Common Stock will be owned by PAG as a result of conversion of SevenScore membership interests; (ii) 3,147,759 shares of RGMP Common Stock being owned by several other SevenScore members; and (iii) 250,000 shares of Regnum Common Stock being owned by the Regnum shareholders, other than PAG, prior to effectiveness of the Merger. The equity holders, or members, of SevenScore will receive a majority of the shares of common stock of Regnum in the merger. The completion of the Merger is subject to satisfaction to submit a Company Related Action Notification in accordance with Financial Industry Regulatory Authority (FINRA) Rule 6490. The board of directors of Regnum and SevenScore have unanimously approved the transaction. PAG, the majority shareholder of Regnum also approved the transaction."

[Chuckles759]

Also, does Regnum have, or will have, funds to make the milestone payments to CYDY when approval comes through?

For a company that is supposed to market/sell/distribute Vyrologix/leronlimab/PRO140 to the US and its Territories, please explain how that's going to be executed with only two employees?

Where is Regnum's sales staff?
Where is Regnum's agreements with health insurance and Medicaid?
What is Regnum's CRM infrastructure?
What is Regnum's ERP infrastructure?
Who are Regnum's channel partners?
Where are Regnum's state level approvals?
Where is Regnum's Board of Directors?
Where are employment contracts with existing Company Officers?

Let's start with connecting those dots and then we can have a serious discussion....

[Chuckles759]

I was just quoting something I saw from Aaron2 on YMB who was laying out their theory.

I see things a little differently. The shakeup at CYDY somewhat jeopardizes their ability with delivering on the BLA/PDUFA so that there *CAN* be some USA selling rights....before Regnum either runs out of cash, the terms of the agreement expire, or some now unforeseen event brings everything crashing down.

What's Regnum's backup plan if CYDY fails to follow through on time...or even follows through?

[SmittyInvestor]

Please explain your "connecting the dots" further
With new mgmt over at CY the USA selling right maybe worth more with the expectation that things will move faster?

Now I see a $13mil market cap, clean shell, pink, with something they can build on. Now they just need to start advertising a plan, hire some people and at least make it look like they are doing something to have this stock price go up.

[Chuckles759]

Interesting take from Aaron2 from YMB. He's seeing the smoke like I am... Just wonder how many fires we're dealing with...

My theory on why NP suddenly had to go. I'm actually surprised no one has made the link between these events yet but here goes

It's speculative but based on a timeline that's factual.

If certainly wasn't because of loose lips on NP part on a proactive video. That wouldn't be enough for a potential partner to holler foul and I am hopeful based on the clues everyone points to we have a big potential partner in the wings.

Something made this partner suddenly holler. The CC was abruptly cancelled two days after it was announced on January 11th.

One day before that on January 10th was a PR from Vyera that they had assigned all their distribution rights to REGNUM Corp.

Regnum is a two persons operation whose stated mission in 2016 was to sell unproduced Hollywood scripts!!!

If it sounds like a joke to you look it up. Here is the link.

https://www.reuters.com/companies/RGMP.PK

And if it sounds like a joke to you that Regnum has EXCLUSIVE distribution rights to Leronlimab in North America, a 2 person company that traded at $.15 cents the day of the announcement, a company that is transforming itself from a Script development company into a pharmaceutical company, imagine what it looked like to any potential partner.

In order for the rights to be assigned they needed NP signature. And he gave it.

January 10th: Regnum deal announced by Vyera

January 11th: 8K released confirming the deal complete with NP signature.

January 13th: CC canceled.

Make your own conclusion.

[Chuckles759]

Not sure how current that info is.

I'm pretty sure they're colocated with Sevenscore on Floor 10 now.

Did you know that in that same building is a law office that initiated a class action suit against CytoDyn? One floor above RGMP's old 19th floor address.... What a coincidence!! Wonder what those odds are?

https://www.globenewswire.com/news-release/2021/05/08/2225864/0/en/SHAREHOLDER-ALERT-Pomerantz-Law-Firm-Investigates-Claims-On-Behalf-of-Investors-of-CytoDyn-Inc-CYDY.html

600 Third Avenue
20th Floor
New York, NY 10016
http://www.pomerantzlawfirm.com
Phone: [phone]
Fax: [phone]

https://profiles.superlawyers.com/new-york/new-york/lawfirm/pomerantz-llp/34ea6092-25a4-48f5-ba2d-b930bf9cc4d8.html

[daemon57]

Is this new? I could've sworn this had 2 people listed as employees not 2 weeks ago..

Address: 600 3RD Ave FL 19 New York, NY, 10016-1901 United States
Phone: [phone]
Website: www.regnumcorp.com External Website. Opens New Window
Employee (all sites): 3
Revenue: $9,000 Fiscal Year End: DEC
Year Started: 2016 Incorporated: 2016
Stock Exchange: Norwegian OTC:RGMP

[daemon57]

Pharma bro banned from Pharma industry:
https://www.cnn.com/2022/01/14/business/martin-shkreli-banned-pharma-bro/index.html

Damn good things you can have shell companies running shell companies that run shell companies that can run ... etc...

Still waiting to place my bet!

[Chuckles759]

Well.... The website is dramatically improving.

http://rovidatx.com
(I can even click "Get this domain".)

At least I know where to get information about Tv and Internet Best..., Carshield Extended, Smartphone, .... and other non-pharma topics.

I wonder how serious Anne Kirby is about representing CytoDyn for HIV sales and marketing....a potentially multi-million dollar enterprise.

Now looks like this...


I will say it's not as exciting as the other web site with the "Other Stuff" content. The new site needs some animated GIFs... or something...

[Chuckles759]

Any juicy rumors on how Regnum is working with the shakeup over at CytoDyn?

Certainly a power vacuum that can be to Regnum's advantage if the right people played their cards right.

[SmittyInvestor]

As much as I hate the spread on this it will keep alot of 'traders" out of this one, investor needs to be committed and believe this company will sell the HIV drugs in US,
which my opinion is should be easy to do as the benefits over current treatments are numerous. selling it should be cake walk if there is a good cost comparison.
Another benefit is they can always get more money from the parent company to fund any worthwhile selling efforts. I find it hard to believe they will fail if they can execute, hope they can

I expect regnum will put a some PR on how they are going to expand and lay groundwork for introducing this HIV drug.

currently a clean, current, pink stock at $22mil+ market cap, I like that as a base, if they do any good moves in HIV medical this will go over $100 mil market cap, lets hope for execution and then performance

[daemon57]

RGMP isn't its usual 100 shares + volume today.
Need this to get a bit more throughput in.
I want to place that buy order.
Need it to fly like Marty McFly!

[Chuckles759]

I think there was a statement of no dillutitive (is that a word...prolly not) financing. But that is probably debatable if these loans and terms execute into common stock.

[albertaguy]

Im going to be honest, if you look at the future notes of every company in the otc its bleak…. People were yelling “dilution dilution dilution” after that big volume day but the update on the otcmarkets site clearly showed there was none….. all I was referring too

[Big Brother]

I'm under the impression that it would increase the o/s by an additional 4M but not 100% sure.

I wish more was known about Sevenscore, very few details, at least the ownership structure, I guess they are subsidiary of Phoenixus and/or Vyera. Just odd that for whatever reason RGMP did not complete the merger with Sevenscore....and instead they structured the deal this way instead....can only speculate on why that was though.

Whatever the case, as long as they keep Marty out of Regnum's business, I'm not too concerned....lol.

[Chuckles759]

Agreed on the toxic lenders....keep it amongst "family" seems to be the best route. Phoenixus AG seems to be doing fairly well...not much transparency on their finances though.

And those 4,094,023 shares to Sevenscore....where are those coming from? Phoenixus AG's shares or will there be more O/S? That's about 5% of authorized....not an insignificant amount.

[Big Brother]

Don't forget about the 4,094,023 shares SevenScore gets as well, per the last 8K.

Honestly, this not very dilutive at all, especially these days, most OTC companies that complete mergers or acquire assets issue tens of millions or hundred of millions of shares now.

Additionally, the $1.5M convertible promissory note is from the Regnum's parent company Phoenixus, not many OTC companies could even dream about getting a loan of this size, especially from the sleazy, toxic lenders most utilize.

Yes, Phoenixus ownership % increases but who cares, higher the better as far as I'm concerned.

https://www.sec.gov/ix?doc=/Archives/edgar/data/1716324/000147793222000165/rgmp_8k.htm

[Chuckles759]

So, If I understand this correctly....

80,000,000 Authorized
22,950,000 Shares Outstanding
22,680,000 Shares held by Phoenixus AG
-----------
270,000 Public Float

Then, from the 10-Q (30Sep21)

"On October 8, 2021, Regnum issued a convertible promissory note in the principal amount of $1,500,000 to its principal shareholder, Phoenixus to support clinical development and general expenses. The principal will bear interest at the rate of 3% per annum, payable on maturity or conversion. The note will mature 365 days following the date of issue, unless earlier repurchased or converted. Phoenixus has an option to convert the principal and interest into common shares of Regnum at $0.40 per share, upon Regnum completing an equity financing of at least an additional $5,000,000 in the aggregate."

That comes out to about 3,862,500 shares common due Oct 8, 2022. If this not is not settled before then, more shares common will need to be registered...then there will be about 26,812,500 S/O.

Small dillution...but it puts the current 1% available shares down to even less.

With the hopeful chance that the CytoDyn HIV BLA being approved in late 2022 and a PDUFA date in mid-2023, Regnum really doesn't have any cashflow for another year.

Is Phoenixus AG going to continue paying the bills? Think that $1.5M is going to get them through Oct 2022....when income from the CytoDyn HIV BLA probably won't be realized until at least mid-2023?

Oh, and how much and when are the milestone payments to CytoDyn due?

Trying to lay this out on a calendar and things aren't matching up.

[albertaguy]

People kept saying dilution on that big volume day….. still showing 270k! This is going to ignite!

[Chuckles759]

Doing some research on the name "Rovida Therapeutics" shows no State of NY filings for DBA or Corporate entity registration.

You'd figure if they asked the SEC for a name change they would have secured the entity name.

And I do see the new rovidatx.com domain registration. The "www.rovidatx.com" is what I would term "A VERY basic web presence".

Will continue to monitor.

[Chuckles759]

A little digging on the Regnumcorp.com domain shows that Apr 2021, someone used a Chinese Internet Domain Registrar to reserve the domain for 1 year. It expires in Apr 2022. Right before Apr 2021 it was dark times for Regnum since they were not making it as an entertainment company and Apr 7, 2021 is when Regnum/Sevenscore made the announcement that Sevenscore was to merge INTO Regnum. I guess the domain registration lapsed/expired during this time and some enterprising entity snatched it up through the Chinese registrar. Typically when you grab a domain and don't make your own web page, the registrar will point your domain to a "parking page" that says something like "coming soon". But with the OTHER STUFF, it almost seems an intentional annoyance.

What I found interesting is that the two physical servers hosting the site "www.regnumcorp.com" are in Boulder, CO and Manassas, VA, respectively, with two different hosting services. Those servers seem to have a configuration to intentionally redirect any requests over to these Chinese language web pages....that are registered to Chinese companies...that are hosted on servers in the US.

Seems a bit less of a coincidence and more of an intentional effort to embarrass or malign.

[$5.95akadawson-m]

I would not want this dark pony to just be a pumper and then sink like a turd.

[daemon57]

What would be the catalyst? Please englighten? Pretty specific about time frame so very curious. TIA.

[halbroke1]

RGMP $$$..COULD SEE MEGA-EXPLOSION COMING NEXT WEEK..

[daemon57]

Shrikeli was just ordered by a higher court to pay back $64mm on 1/14/2022:

https://finance.yahoo.com/news/ny-attorney-general-announces-martin-211154276.html#:~:text=Disgraced%20%E2%80%9Cpharma%20bro%E2%80%9D%20Martin%20Shkreli,according%20to%20The%20Associated%20Press.

If I had to take a guess, due to RGMP's low volume and the connection that Martin has with the shell companies and it's subsidiaries, this will trade trending upwards for some time until he can make this payment.

Of course, ALL IMHO.

I'm still looking to put $200 on this horse, waiting for entry.

GLTU/A.

[Big Brother]

Share structure updated @ OTC Markets......no changes.

I was not 100% sure, after seeing the float turn over 1 1/2 times on Monday, which was rather unusual but there it is....no increases or changes at all in the unrestricted or shares held @ DTC.

https://www.otcmarkets.com/stock/RGMP/security

[GemBerri]

He has a great pedigree, graduating from a school with known history of cheating. Guess that’s how one would learn his craft

https://nypost.com/2012/06/24/students-say-they-blew-whistle-on-cheating-at-baruch-colleges-zicklin-school-of-business/

https://www.nytimes.com/2012/12/20/nyregion/baruch-business-program-administrator-pleads-guilty-after-changing-grades.html

[$5.95akadawson-m]

Absolutely right, although, today, a judge mandated that he pay back 64 million from bilking patients. So he will not be a threat anytime soon.

[GemBerri]

That’s a good point Chuckles…I guess we shall see his next move. He will be out some time this year… but ain’t nothing is stopping him from pulling the strings behind bars.

[$5.95akadawson-m]

That's my fear. But it sure isn't acting illiquid; however, you buy $250 worth and some guy who's been holding that bag for five years will grab yours. That's what I think..

[$5.95akadawson-m]

The whole thing is made up. Like a doll. But a pretty one and it's .80 cents. It'll be a buck soon enough.

[$5.95akadawson-m]

I heard that CYYDY is gonna be over $1 next Tuesday. Buy with both hands for Reggie. The King.!

[$5.95akadawson-m]

OMG! If you two are here, it only means one thing. Money. Big money.

[Chuckles759]

The 30Sep21 version of the 10-Q says this:

Ms. Anne Kirby, our Chief Executive Officer, has not served as an officer or director of a publicly traded company.

But isn't she also the CEO of Sevenscore...which really *IS* a big thing?

Will Anne Kirby still have the time/bandwidth to manage both companies effectively?

[Chuckles759]

I'm curious about this mention of "SSP-002" from the prior 10-Q (30Jun21) that was removed in the amended 10-Q. It looked like Regnum was going to market/distribute this drug via the Sevenscore merger that was called off.

Spherical Nucleic Acid
Exicure’s discovery and development efforts are based on proprietary Spherical Nucleic Acid, or SNA™, technology. SNAs are nanoscale constructs consisting of synthetic nucleic acid sequences. The design of Exicure’s SNAs gives rise to distinct chemical and biological properties and may provide advantages over other nucleic acid therapeutics.

SSP-002 is a targeted therapy for the treatment of Netherton Syndrome (NS). NS is a rare and severe autosomal recessive disorder caused by loss-of-function mutations in the SPINK5 gene, which encodes the serine protease inhibitor LEKTI involved in skin barrier function. NS affects approximately 1 in 200,000 children born each year, and is characterized by severely inflamed, red, scaled, itchy skin, and patients are at increased risk of mortality in the first year of life due to recurrent infections and dehydration as a result of the impaired skin barrier. Currently, there are no approved treatments for NS patients and off-label use of standard of care treatments are of limited utility.

Sounds interesting.

[Chuckles759]

I think that only applies to US companies.

Parent company of Regnum is Phoenixus AG...the former Turing Pharma...Shkreli's gig. He can pull strings from that distance...Anne Kirby will probably be more than happy to charge Regnum with an endless string of fees since there isn't any employment agreement with ANY of the Regnum directors....all two of them.

[daemon57]

Potentially and perhaps looking to purchase $100 for a gamble. Let's see how much I can make (or lose).

This is not investment advice.

[GemBerri]

Various reports wrote that he is planning a comeback in the pharma industry, now it appears that he will not be able to, at least not legally.

https://news.yahoo.com/shkreli-ordered-return-64m-barred-192335816.html

[GemBerri]

Is the plan for sales force from SevenScore to merge with Regnum to commercialize leronlimab?

[atr3f]

Without any sort of IR, I doubt this little volume even continues much longer, its already super illiquid and hopefully with draw some attention in light of recent news (time to move on from motion pictures!).

[atr3f]

Good point, and thanks for the link. Will be interesting to see what comes of this.

[atr3f]

Agreed -- this is a classic shell stock that is grasping for any possible assets with value.

[atr3f]

Its not surprising you can't locate the IR for this company, heck the SEC filings still think this shell is in the motion picture business. The deal with CYDY takes it to an entirely different direction.....